NASDAQ:RKLB - Nasdaq - US7731221062 - Common Stock - Currency: USD
Rocket Lab topped Q1 estimates, with analyst citing Neutron momentum and raising FY25 EPS outlook on strong revenue growth expectations.
Rocket Lab USA (RKLB) delivered earnings and revenue surprises of -20% and 1.59%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: SPCE
Aerospace and defense company Rocket Lab (NASDAQ:RKLB) announced better-than-expected revenue in Q1 CY2025, with sales up 32.1% year on year to $122.6 million. On the other hand, next quarter’s revenue guidance of $135 million was less impressive, coming in 1.7% below analysts’ estimates. Its GAAP loss of $0.12 per share was in line with analysts’ consensus estimates.
Katy Perry kissed the sky – and she liked it. Sure, it was a stunt, but Blue Origin’s recent all-female spaceflight wasn’t just for show. It spotlighted a fast-evolving commercial space economy that’s already deeply woven into our daily lives. From satellite-powered TV and GPS to real-time Earth imaging, space tech keeps the world spinning. And this is just liftoff – there’s no telling how far beyond the final frontier the space economy could go. For now, we can measure it in dollar terms. Accor
Aerospace and defense company Rocket Lab (NASDAQ:RKLB) will be reporting results tomorrow after market close. Here’s what investors should know.
This space stock is growing quickly and has a lot of irons in the fire.
Investors interested in RKLB should refrain from adding this stock to their portfolio before Thursday, considering its premium valuation.
Rocket Lab’s first-quarter 2025 earnings report on May 8 comes amid high expectations, mixed sentiment, and significant short interest.
Rocket Lab's a winner, but perhaps not quite as big a winner as this news makes you think.
We recently published a list of These 10 Firms Soared Last Week, Here’s Why. In this article, we are going to take a look at where DexCom Inc. (NASDAQ:DXCM) stands against other firms that soared last week. The past trading week saw a more calm, generally optimistic, market environment amid the temporary pause in tit-for-tat […]
TSMC, ASML, and Arm still look like a great long-term plays in the growing market.
Nvidia’s (NVDA) shares are not fully pricing in all of its upbeat catalysts, and it’s “certainly a buy,” Keybanc analyst John Vinh told Yahoo Finance recently. Moreover, it’s “a bit premature” to be concerned about Nvidia’s competition from custom AI chip makers, Vinh believes. NVDA’s Attractive Valuation NVDA stock is failing to price in “everything,” […]
Rocket Lab USA (RKLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: LDOS
These companies are underrated and growing quickly.
There's a good reason most analysts don't try to make guesses this far in the future.
An acceleration in this semiconductor company's growth, combined with its cheap valuation, makes it a no-brainer buy right now. Share prices of Lam Research (NASDAQ: LRCX) shot up more than 6% following the April 23 release of its fiscal 2025 third-quarter earnings (for the three months ended March 30), driven by the company's stronger-than-expected results and guidance that point toward strong demand for its semiconductor manufacturing equipment. Let's take a closer look at the factors driving Lam's growth and examine why this semiconductor stock is worth buying hand over fist right now.
Investors are advised to remain on the sidelines for now, as current fundamentals do not support a buying opportunity in either LUNR or RKLB
Mentions: LUNR
Rocket Lab USA, Inc. (RKLB) closed the most recent trading day at $22.40, moving -1.19% from the previous trading session.
Investors interested in space stocks should refrain from adding LUNR to their portfolio right now, considering its premium valuation.
Investors should adopt a wait-and-watch approach for RKLB and PL stocks, considering their negative ROE and downward earnings revisions.
Mentions: PL